Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Mantle-Cell 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma, Follicular 12Lymphoma 12Leukemia, Lymphocytic, Chronic, B-Cell 12Lymphoma, Large-Cell, Immunoblastic 11Burkitt Lymphoma 11Lymphoma, B-Cell, Marginal Zone 10Hodgkin Disease 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia 5Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Acute 4Immunoblastic Lymphadenopathy 4Ovarian Neoplasms 3Breast Neoplasms 3Waldenstrom Macroglobulinemia 2Triple Negative Breast Neoplasms 2Sezary Syndrome 2Sarcoma 2Pancreatic Neoplasms 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lung Neoplasms 2Kidney Neoplasms 2Intraocular Lymphoma 2Hematologic Neoplasms 2Glioma 2

Interventions

Vinorelbine 1Paclitaxel 1Estramustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosarcoma × Paclitaxel × Other hematologic neoplasm × Clear all
NCT00004105 2011-03-28

Combination Chemotherapy in Treating Patients With Advanced Cancer

NYU Langone Health

Phase 1/2 Completed
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fibrosarcoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Sarcoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡